FRNM · Nasdaq · CIK 0002017526

Freenome, Inc.

Freenome, Inc.’s most recent SEC filing in our snapshot is a Form 424B3 filed on Oct 20, 2026. Its EDGAR record lists 9 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
—
Net income, FY2025
$837.5K
Form 4 filings on record, past 12 months
9

Company overview

Legal name (as filed)
Freenome, Inc.
Ticker
FRNM
SEC Central Index Key (CIK)
0002017526
Industry (SIC)
Services-Medical Laboratories (code 8071)
Business address
BRISBANE, CA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
<br>Emerging growth company
Position in SEC ticker list
#2229 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Freenome, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
n/aFY2025
Net income
$837.5KFY2025
FRNM annual results
ItemFY2025
ended Dec 31, 2025
Revenue—
Net income$837.5K
Diluted EPS—
Total assets$92.8M
Cash and equivalents$865.0K

XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

FRNM latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 12, 202610-KAnnual report· period Dec 31, 2025Document · Index
Jul 15, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 20, 20268-KRegulation FD disclosure; Other events· period Oct 20, 2026Document · Index
May 14, 2026DEF 14ADEF14A· period Jun 10, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Freenome, Inc., by form type:

3 ×104 ×9SCHEDULE 13G ×4SCHEDULE 13G/A ×48-K ×3424B3 ×2EFFECT ×2POS AM ×2S-8 ×1S-1 ×18-K/A ×1SCHEDULE 13D/A ×1
FRNM recent filings
FiledFormWhat it isOriginal
Oct 20, 2026424B3424B3Document · Index
Oct 20, 20268-KRegulation FD disclosure; Other events· period Oct 20, 2026Document · Index
Sep 23, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Sep 4, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 2, 2026Document · Index
Sep 1, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 27, 2026EFFECTEFFECTDocument · Index
Aug 27, 2026424B3424B3Document · Index
Aug 18, 2026S-1Registration statement (IPO and other offerings)Document · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 14, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 13, 20268-K/AAcquisition or disposition completed· period Jul 20, 2026Document · Index
Aug 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 5, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 29, 2026EFFECTEFFECTDocument · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 28, 2026POS AMPOS AMDocument · Index
Jul 27, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 27, 20268-KRegulation FD disclosure; Other events· period Jul 27, 2026Document · Index
Jul 24, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 24, 2026POS AMPOS AMDocument · Index
Jul 24, 20268-KMaterial agreement; Acquisition or disposition completed; Unregistered equity sale; Change to shareholder rights; Auditor change; Change in control; Director or officer change; Charter, bylaws or fiscal year change; Code of ethics change; Shell company status change; Regulation FD disclosure; Other events· period Jul 20, 2026Document · Index
Jul 23, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 23, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 22, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Jul 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index
Jul 22, 20263Initial statement of beneficial ownership· period Jul 20, 2026Document · Index
Jul 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 20, 2026Document · Index

Insider filing activity

9 Form 4 filings appear in Freenome, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-Medical Laboratories

All 17 companies in Services-Medical Laboratories· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0002017526 and XBRL company facts. Freenome, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.